Lv01
0 积分 2024-11-08 加入
VV116 or Nirmatrelvir–Ritonavir for Oral Treatment of Covid-19
2小时前
待确认
Small-molecule anti-COVID-19 drugs and a focus on China’s homegrown mindeudesivir (VV116)
2小时前
已完结
VV116 as a potential treatment for COVID-19
2小时前
已完结
Oral VV116 versus placebo in patients with mild-to-moderate COVID-19 in China: a multicentre, double-blind, phase 3, randomised controlled study
2小时前
已完结
皖公网安备34019202002308
